What is the risk of contrast-induced nephropathy (CIN) in a patient with impaired renal function, specifically a glomerular filtration rate (GFR) of 25, undergoing a computed tomography (CT) angiogram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The risk of contrast-induced nephropathy (CIN) is significantly elevated in a patient with a GFR of 25 undergoing CT angiography, with an estimated risk of approximately 10-20%. For this patient, I would recommend careful consideration of whether the CT angiogram is absolutely necessary. If the study must proceed, preventive measures should include:

  • Pre-procedure hydration with isotonic saline (1 mL/kg/hr for 6-12 hours before and after the procedure) 1
  • Using the minimum necessary dose of iso-osmolar or low-osmolar contrast media 1
  • Temporarily discontinuing nephrotoxic medications like NSAIDs and metformin 48 hours before the procedure 1
  • N-acetylcysteine (600-1200 mg orally twice daily the day before and day of the procedure) may be considered, though evidence for its effectiveness is mixed 1 The patient's renal function should be monitored with serum creatinine measurements at 24-48 hours after the procedure. CIN risk is elevated because the contrast media causes renal vasoconstriction and direct tubular toxicity, which can worsen existing kidney dysfunction, particularly in patients with GFR below 30 mL/min/1.73m². Some key points to consider:
  • The use of low-osmolar or iso-osmolar contrast media is recommended for patients with moderate-to-severe CKD 1
  • The volume of contrast media should be minimized 1
  • Hydration with isotonic saline is recommended for patients with moderate-to-severe CKD 1
  • Short-term, high-dose statin therapy may be considered for patients at high risk of CIN 1

From the FDA Drug Label

  1. 3 Contrast-Induced Acute Kidney Injury Acute kidney injury, including renal failure, may occur after iodixanol administration Risk factors include: pre-existing renal impairment, dehydration, diabetes mellitus, congestive heart failure, advanced vascular disease, elderly age, concomitant use of nephrotoxic or diuretic medications, multiple myeloma/paraproteinaceous diseases, repetitive and/or large doses of an iodinated contrast agent.

The risk of contrast-induced nephropathy in a patient with a GFR of 25 is increased due to the presence of pre-existing renal impairment, which is a risk factor for contrast-induced acute kidney injury.

  • Key risk factors for this patient include:
    • Pre-existing renal impairment (GFR of 25)
    • Potential for dehydration
    • Potential for concomitant use of nephrotoxic or diuretic medications To minimize the risk, it is recommended to use the lowest necessary dose of iodixanol and adequately hydrate the patient prior to and following iodixanol administration 2.

From the Research

Risk of Contrast-Induced Nephropathy in CT Angiogram

  • The risk of contrast-induced nephropathy (CIN) is a significant concern in patients with pre-existing renal impairment, such as those with a glomerular filtration rate (GFR) of 25 3, 4.
  • CIN is commonly defined as a decline in kidney function occurring after administration of iodinated contrast agents, and it can lead to more permanent renal insufficiency, dialysis, and death 3.
  • The incidence of CIN has been reported to range from 0% to 24%, depending on the definition, background risk factors, type and dose of contrast medium used, and the frequency of other coexisting potential causes of acute renal failure 4.

Prevention Strategies

  • Minimizing the amount of contrast administered and providing adequate hydration are the cornerstones of an effective preventative approach to reduce the risk of CIN 3, 4.
  • Hydration with sodium bicarbonate has been shown to decrease the incidence of CIN compared to hydration with normal saline 5.
  • The use of N-acetylcysteine (NAC) in addition to bicarbonate hydration has been investigated, but its effectiveness in preventing CIN is still unclear 6.

Patient-Specific Risk Factors

  • Patients with chronic renal failure (CRF) are at higher risk of developing CIN, and those with a GFR of 25 are considered to be at high risk 6, 7.
  • Other risk factors for CIN include older age, diabetes, volume depletion, sepsis, and use of nephrotoxic drugs 7.
  • Careful selection of patients and avoidance of nephrotoxic agents pre- and post-procedure are crucial in preventing CIN 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2018

Research

Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009

Research

Contrast-induced nephropathy.

Critical care clinics, 2005

Related Questions

Can an 88-year-old male with impaired renal function, as indicated by a creatinine (Cr) level of 1.16, blood urea nitrogen (BUN) of 55, and glomerular filtration rate (GFR) of 60.6, undergo a computed tomography (CT) scan of the pelvis and abdomen with contrast, or should laboratory tests be repeated first?
Can intravenous (IV) contrast media cause kidney injury in patients with impaired renal function?
How to prevent contrast-induced nephropathy in patients with pre-existing kidney disease or significant proteinuria?
What is the next step in managing a patient who noticed possible hematuria and foamy urine after a contrast‑enhanced CT scan?
What are the concerns with using Intravenous (IV) contrast in a patient undergoing Hemodialysis (HD) due to Impaired renal function?
What is the significance of Left Ventricular Hypertrophy (LVH) diagnosed using the Sokolow-Lyon (SL) index and Cornell product?
What is the appropriate dose of Gabapentin (Gabapentin) in a patient with Chronic Kidney Disease (CKD) stage 4, characterized by Impaired Renal Function?
What is the risk of contrast-induced neuropathy in a patient with impaired renal function (GFR of 25) undergoing a Computed Tomography (CT) angiogram?
What is the diagnosis and treatment for cellulitis?
What is the oral (po) to intravenous (iv) conversion for Metoprolol (Lopressor)?
How to rapidly taper and discontinue guanfacine (Intuniv) Extended Release (ER) 2 milligrams in an 8-year-old child experiencing severe aggression, as prescribed by a psychiatrist?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.